Erasca (ERAS) Form 144: Erasca Foundation lists multiple common-stock sale dates

Rhea-AI Filing Summary

Erasca, Inc. Form 144 filing notifies proposed sales of Common stock by the Erasca Foundation as reported on the form. The filing lists multiple entries with a recurring figure 8333 associated with each sale line and transaction dates such as 02/17/2026, 01/15/2026, and 12/15/2025.

Examples shown include Erasca Foundation entries dated 02/17/2026 (8333) and 01/15/2026 (8333). The filing identifies Nasdaq as the market and includes an apparent reporting date of 03/16/2026.

Insights

Securities Compliance Attorney

Form 144 documents proposed affiliate sales of common stock by a foundation.

The form lists multiple proposed sale lines attributed to the Erasca Foundation with repeated numeric entries of 8333 and specific transaction dates including 02/17/2026. This indicates routine affiliate reporting of planned dispositions under Section 144 procedures.

Timing and cash‑flow treatment are tied to the listed dates; amounts and exact sale mechanics are limited to the lines shown. Subsequent SEC filings or broker confirmations would show settlement details.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Merrill Lynch 6002 El Tordo PO Box 7297 Rancho Santa Fe CA 92067	8333	116855.46	283711805	03/16/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	07/20/2021	Donation	Erasca, Inc.			10193557	07/20/2021	Donation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Erasca Foundation 3115 MERRYFIELD ROW STE 300 San Diego CA 92121	Common	02/17/2026	8333	99245.03
Erasca Foundation 3115 MERRYFIELD ROW STE 300 San Diego CA 92121	Common	01/15/2026	8333	68573.87
Erasca Foundation 3115 MERRYFIELD ROW STE 300 San Diego CA 92121	Common	12/15/2025	8333	30438.69

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Erasca (ERAS) Form 144 disclose about the transaction?

The Form 144 discloses proposed sales of Common stock by the Erasca Foundation, listing multiple entries with the figure 8333 and dates including 02/17/2026. It records the market as NASDAQ and a reporting date of 03/16/2026.

Who is the selling party in the ERAS Form 144 filing?

The selling party listed is the Erasca Foundation, with an address in San Diego, CA. The form shows multiple sale lines attributed to that foundation and associated transaction dates.

Which dates are associated with the sales in the Form 144 for ERAS?

The filing lists transaction dates including 02/17/2026, 01/15/2026, and 12/15/2025, with a form reporting/reference date of 03/16/2026 shown on the cover lines.

Does the Form 144 show how many shares Erasca Foundation is offering?

The form repeatedly lists the numeric entry 8333 alongside each sale line, presented as part of the securities lines. The filing excerpt does not aggregate or label a single total offered amount.

Which market is referenced in the ERAS Form 144?

The filing identifies the market as NASDAQ on the securities information lines. No additional trading venue details are provided in the excerpt.